Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 favipiravir versus placebo for uncomplicated influenza in adults
NL-OMON40560Phase 3Active, not recruiting
- Sponsor
- MDVI, LLC
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Favipiravir with Placebo (2 arms). Primary endpoint: Time to alleviation of all primary influenza symptoms and fever resolution. Started Mar 2014; status: active, not recruiting.
02
Drugs
favipiravir
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON40560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40560.